BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Kronos Bio, Inc. (Nasdaq - KRON), Regulus Therapeutics Inc. (Nasdaq – RGLS), Longevity Health Holdings, Inc. (Nasdaq - XAGE), Southern States Bancshares, Inc. (Nasdaq - SSBK)
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 15 2025
0mins
Source: Globenewswire
Investigation Announcements: Brodsky & Smith is investigating potential breaches of fiduciary duties by the boards of several companies, including Regulus Therapeutics, Kronos Bio, Longevity Health Holdings, and Southern States Bancshares, regarding their merger agreements and whether shareholders are receiving fair value for their shares.
Merger Details: Each company mentioned has entered into merger agreements with specified cash payments or stock exchanges, raising concerns about the fairness of these transactions and the protection of shareholder interests.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
